Table 3 IgG antibodies to ganglioside complexes in patients with Fisher syndrome overlapping Guillain–Barré syndrome
VentilatedUnventilated
No of patients IgG antibodies to:1134
n (%)n (%)
    cM1/M20 (0%)0 (0%)
    cM1/D1a1 (9%)8 (24%)
    cM1/D1b5 (45%)6 (17%)
    cM1/T1a3 (27%)17 (50%)
    cM1/T1b2 (18%)3 (9%)
    cM1/Q1b3 (27%)14 (41%)
    cM2/D1a0 (0%)1 (3%)
    cM2/D1b0 (0%)1 (3%)
    cM2/T1a2 (18%)7 (21%)
    cM2/T1b1 (9%)1 (3%)
    cM2/Q1b1 (9%)12 (35%)
    cD1a/D1b3 (27%)3 (9%)
    cD1a/T1a4 (36%)12 (35%)
    cD1a/T1b2 (18%)1 (3%)
    cD1a/Q1b3 (27%)12 (35%)
    cD1b/T1a3 (27%)15 (44%)
    cD1b/T1b1 (9%)4 (12%)
    cD1b/Q1b2 (18%)12 (35%)
    cT1a/T1b3 (27%)15 (44%)
    cT1a/Q1b1 (9%)4 (12%)
    cT1b/Q1b3 (27%)10 (29%)
    Any of the above complexes9 (82%)29 (85%)
  • cM1/D1a, designated complex of GM1 and GD1a; and similar in the following 20 antigens.